Home » Internet » Merck cites EnWave\-\-s REV? Technology as a Faster, Viable Drying Alternative to Vial-Based Lyophilization for Vaccines and Biologics
Merck cites EnWave\-\-s REV? Technology as a Faster, Viable Drying Alternative to Vial-Based Lyophilization for Vaccines and Biologics Posted by PublisherInternet Tuesday, 26. January 2021
EnWave Corporation (TSX-V:ENW | FSE:E4U) (?EnWave?, or the ?Company? https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/)?announces today that Merck & Co. Inc (?Merck?) published a research paper citing ?EnWave?s freezeREV? process as a viable manufacturing alternative to vial-based lyophilization for vaccines and biologics. The research article entitled ?Evaluation of Microwave Vacuum Drying as an Alternative to Freeze-Drying of Biologics and Vaccines: The Power of Simple Modeling to Identify a Mechanism for Faster Drying Times Achieved with Microwave? was published in the January 19, 2021 edition of PharmSciTech, the official